The U.S. Department of Commerce (DOC) on December 19, 2025, announced the final determinations in its antidumping duty (ADD) and countervailing duty (CVD) investigations of Hard Empty Capsules (HEC) from Brazil, China, India, and Vietnam. GDLSK represented Shanxi JC Biological Co., Ltd. (JC), a Chinese producer and exporter of HECs. JC was the only company in the four countries that DOC found not dumping. As a result, JC will not be subject to the ADD order on HECs from China that is expected to issue (if the International Trade Commission finds material injury). DOC also found that JC’s CVD rate was merely 8.81%. JC’s combined ADD/CVD rate was the lowest of all companies in all investigated countries.
GDLSK is proud to have secured this result for JC. If you have questions about these HEC investigations, please contact GDLSK Partners Jordan C. Kahn or Michael S. Holton.
